Guangdong Jiaying Pharmaceutical Co Ltd (002198) - Total Assets
Based on the latest financial reports, Guangdong Jiaying Pharmaceutical Co Ltd (002198) holds total assets worth CN¥892.78 Million CNY (≈ $130.64 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check 002198 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Guangdong Jiaying Pharmaceutical Co Ltd - Total Assets Trend (2004–2025)
This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Explore how much of Guangdong Jiaying Pharmaceutical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Guangdong Jiaying Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Guangdong Jiaying Pharmaceutical Co Ltd's total assets of CN¥892.78 Million consist of 59.2% current assets and 40.8% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 19.4% |
| Accounts Receivable | CN¥136.72 Million | 16.1% |
| Inventory | CN¥74.04 Million | 8.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥76.11 Million | 9.0% |
| Goodwill | CN¥0.00 | 0.0% |
Asset Composition Trend (2004–2025)
This chart illustrates how Guangdong Jiaying Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Guangdong Jiaying Pharmaceutical Co Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Guangdong Jiaying Pharmaceutical Co Ltd's current assets represent 59.2% of total assets in 2025, an increase from 25.1% in 2004.
- Cash Position: Cash and equivalents constituted 19.4% of total assets in 2025, up from 3.3% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, unchanged from 8.0% in 2004.
- Asset Diversification: The largest asset category is accounts receivable at 16.1% of total assets.
Guangdong Jiaying Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Guangdong Jiaying Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
AstraZeneca PLC
F:ZEGA
|
Germany | €114.46 Billion |
|
AstraZeneca PLC
NASDAQ:AZN
|
USA | $114.02 Billion |
|
Novartis AG
SW:NOVN
|
Switzerland | CHF118.89 Billion |
|
Pfizer Inc
SA:PFIZ34
|
Brazil | R$207.62 Billion |
|
Pfizer Inc
NYSE:PFE
|
USA | $207.62 Billion |
|
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096
|
China | CN¥3.80 Billion |
|
Hunan Jingfeng Pharmaceutical
SHE:000908
|
China | CN¥877.99 Million |
|
Zhejiang Int'L Group Co Ltd
SHE:000411
|
China | CN¥17.31 Billion |
Guangdong Jiaying Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 4.25 | 9.90 | 5.12 |
| Quick Ratio | 3.80 | 8.51 | 4.19 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥414.15 Million | CN¥475.86 Million | CN¥367.49 Million |
Guangdong Jiaying Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Guangdong Jiaying Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.72 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | 1.2% |
| Total Assets | CN¥849.23 Million |
| Market Capitalization | $247.30 Million USD |
Valuation Analysis
Below Book Valuation: The market values Guangdong Jiaying Pharmaceutical Co Ltd's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Guangdong Jiaying Pharmaceutical Co Ltd's assets grew by 1.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
The table below shows the annual total assets of Guangdong Jiaying Pharmaceutical Co Ltd from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥849.23 Million ≈ $124.27 Million |
+1.24% |
| 2024-12-31 | CN¥838.82 Million ≈ $122.75 Million |
-1.03% |
| 2023-12-31 | CN¥847.56 Million ≈ $124.03 Million |
+0.11% |
| 2022-12-31 | CN¥846.65 Million ≈ $123.89 Million |
+4.87% |
| 2021-12-31 | CN¥807.34 Million ≈ $118.14 Million |
-0.14% |
| 2020-12-31 | CN¥808.44 Million ≈ $118.30 Million |
-5.55% |
| 2019-12-31 | CN¥855.94 Million ≈ $125.25 Million |
-3.78% |
| 2018-12-31 | CN¥889.56 Million ≈ $130.17 Million |
+1.48% |
| 2017-12-31 | CN¥876.61 Million ≈ $128.28 Million |
-20.25% |
| 2016-12-31 | CN¥1.10 Billion ≈ $160.86 Million |
+4.89% |
| 2015-12-31 | CN¥1.05 Billion ≈ $153.35 Million |
+1.23% |
| 2014-12-31 | CN¥1.04 Billion ≈ $151.49 Million |
+12.65% |
| 2013-12-31 | CN¥919.00 Million ≈ $134.48 Million |
+192.45% |
| 2012-12-31 | CN¥314.25 Million ≈ $45.98 Million |
+2.51% |
| 2011-12-31 | CN¥306.55 Million ≈ $44.86 Million |
+1.89% |
| 2010-12-31 | CN¥300.87 Million ≈ $44.03 Million |
+18.77% |
| 2009-12-31 | CN¥253.33 Million ≈ $37.07 Million |
+7.69% |
| 2008-12-31 | CN¥235.24 Million ≈ $34.42 Million |
-4.17% |
| 2007-12-31 | CN¥245.48 Million ≈ $35.92 Million |
+104.48% |
| 2006-12-31 | CN¥120.05 Million ≈ $17.57 Million |
+31.59% |
| 2005-12-31 | CN¥91.23 Million ≈ $13.35 Million |
+26.85% |
| 2004-12-31 | CN¥71.92 Million ≈ $10.52 Million |
-- |
About Guangdong Jiaying Pharmaceutical Co Ltd
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat, cold, orthopedics, rheumatism, gynecology, heat-clearing, tonic, and gastrointestinal diseases. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablet… Read more